Patent · US Active

Heterocyclic compounds and uses thereof

US11541059B2 · kind B2 · utility

2Cited by

248References

11Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Jeffery L. Kutok · Natick, US
David G. Winkler · Arlington, US
Vito J. Palombella · Needham, US
Alfredo C. Castro · Woburn, US
Catherine A. Evans · Somerville, US
Somarajannair Janardanannair · Woburn, US
Andre Lescarbeau · Somerville, US
Tao Liu · Shanghai, CN
Martin Tremblay · Waltham, US

Key dates

Filing date	Mar 11, 2020
Grant date	Jan 3, 2023
Priority date	—
Expiry date	Mar 11, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.